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Abstract
The synthesis of nitrogen-containing heterocycles, including natural alkaloids and other compounds presenting different types of bi-
ological activities have proved to be successful employing chiral sulfinyl imines derived from tert-butanesulfinamide. These imines
are versatile chiral auxiliaries and have been extensively used as eletrophiles in a wide range of reactions. The electron-with-
drawing sulfinyl group facilitates the nucleophilic addition of organometallic compounds to the iminic carbon with high diastereo-
isomeric excess and the free amines obtained after an easy removal of the tert-butanesulfinyl group can be transformed into
enantioenriched nitrogen-containing heterocycles. The goal of this review is to the highlight enantioselective syntheses of hetero-
cycles involving the use of chiral N-tert-butanesulfinyl imines as reaction intermediates, including the synthesis of several natural
products. The synthesis of nitrogen-containing heterocycles in which the nitrogen atom is not provided by the chiral imine will not
be considered in this review. The sections are organized according to the size of the heterocycles. The present work will compre-
hensively cover the most pertinent contributions to this research area from 2012 to 2020. We regret in advance that some contribu-
tions are excluded in order to maintain a concise format.
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Scheme 1: General strategy for the enantioselective synthesis of N-containing heterocycles from N-tert-butanesulfinyl imines.
Intoduction
Chiral imines derived from tert-butanesulfinamide have been
extensively used as electrophiles in a wide range of reactions.
The presence of the chiral electron-withdrawing sulfinyl group
facilitates the nucleophilic addition of organometallic com-
pounds to the iminic carbon [1-3]. The ready availability of
both enantiomers of tert-butanesulfinamide in large-scale pro-
cesses, the easy deprotection of the amine under mild acidic
conditions, and a practical procedure for recycling the chiral
auxiliary [4,5] have contributed to the widespread use of these
imines as precursors of chiral compounds with a nitrogen atom
bonded to a stereogenic center. The amine derivatives, result-
ing after removal of the tert-butanesulfinyl group, can be trans-
formed into enantioenriched nitrogen-containing heterocycles
[6,7] including natural alkaloids [8-11] and other compounds
that show different types of biological activities [12,13]. The
way to achieve these transformations is by intramolecular cycli-
zations, involving the free primary amine, and appropriate reac-
tive positions (those positions bearing a leaving group) in the
electrophile or in the carbonyl component of the starting imine
(Scheme 1).
Synthesis of tert-butane N-sulfinyl imines
The first method developed for the synthesis of enantiomerical-
ly pure N-tert-butanesulfonamide 1 was reported by Ellman and
co-workers [14,15]. In 1999, they described the synthesis of
imines from the condensation reaction of aldehydes or ketones
with tert-butanesulfinamides. In this work, the condensation
with aldehydes was carried using Ti(OEt)4 in tetrahydrofuran
(THF), or CuSO4 in dichloromethane at room temperature. The
combination of MgSO4 in the presence of a catalytic amount of
pyridinium p-toluenesulfonate (PPTS) also worked well to
perform these condensations [1,16]. For the formation of
aldimines, other methodologies are described in the literature
using condensation reagents such as Yb(OTf)3 [17], Cs2CO3
[18] and KHSO4 [19]. However, for the synthesis of ketimines,
Ti(OEt)4 was the only effective reagent when performing the
reaction at 60 °C in THF [16]. Ketimines were also synthesized
with Ti(OEt)4, under microwave irradiation in a solvent-free
system [20]. In hindered ketones, Ti(OiPr)4 or Ti(OEt)4 using
vacuum or under a nitrogen flow were effective to tert-butane-
sulfinyl ketimine condensation (Scheme 2) [21].
Mechanism of addition of nucleophiles to
N-sulfinyl imines
The p-toluenesulfinamide 5 was first described by Davis and
co-workers in a racemic form [22], and subsequently, the com-
pound was prepared and isolated as a single enantiomer [23,24],
becoming an important tool in the asymmetric synthesis of
aziridines [25,26], α-amino acids [27,28], β-amino acids [23,29]
and branched α-amines [30,31]. The Darzens-type asymmetric
synthesis of N-(p-toluenesulfinyl)aziridine 2-carboxylate esters
(7 and 8) was described through the addition of lithium
α-bromoenolates to enantiopure p-toluenesulfinamide 5. cis-
aziridine 7a was formed as the major diastereoisomer in 89%
yield and the trans-isomer in 8% yield in a one-step procedure
using lithium enolates of methyl bromoacetate 6a and sulfinyl
imine 5. Lithium enolates of methyl α-bromopropionate gave
trans-aziridine in 50% yield under the same conditions. The
transition state is proposed with a six-membered chair-like tran-
sition containing a four-membered metallocycle. In cis-aziri-
dine the enolate of methyl α-bromoacetate has E-geometry and
the trans-aziridine 8a has Z-geometry [32,33]. In the transition
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
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Scheme 2: Methodologies for condensation of aldehydes and ketones with tert-butanesulfinamides (1).
Scheme 3: Transition models for cis-aziridines and trans-aziridines.
state, the metal cation of the enolate is being coordinated with
both nitrogen and oxygen atoms of the sulfinimine [25,26]
(Scheme 3).
In 1999, Ellman and co-workers described the reduction of
sulfinyl imines using sodium borohydride (NaBH4) [34] or o
ʟ-selectride [35]. Davis–Ellman transition state models were
proposed to rationalize organometallic additions to N-sulfinyl
imines. The mechanism for obtaining these two stereoisomers
was elucidated in the work published by Andersen and co-
workers [36]. The origin of the reversal of the diastereofacial
selectivity on the change of reducing agents is based on the
operating transition states [37,38]. A cyclic transition state is
proposed in the reaction with sodium borohydride. In this tran-
sition state, the oxygen of the sulfinyl group interacts with the
boron atom, facilitating the release of the hydride, directing the
attack to the Si-face of the imine with (RS,E) configuration.
When the reduction is performed with ʟ-selectride, with the
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
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Scheme 4: Mechanism for the reduction of N-tert-butanesulfinyl imines.
poorly coordinating metal hydride, an open transition state
operates due to the bulkiness of the isobutyl groups bonded to
the boron atom. In this case, the attack of the hydride takes
place to the less hindered Re-face of the imine (Scheme 4)
[1,36].
The nucleophilic addition reactions to N-tert-butanesulfinyl
imines were also described by Ellman and co-workers who re-
ported the addition of allylmagnesium bromide to ketimines.
The employment of Grignard reagents showed greater dia-
stereoselectivity than reactions using organolithium and
organocerium compounds. In some examples, the use of
organolithium is feasible through the use of aluminum-derived
additives [15]. In this study, the influence of solvents on dia-
stereoselectivity was also observed. They found that the reac-
tions performed in noncoordinating solvents, such as toluene
and dichloromethane, took place with high diastereoselectivity.
However, solvents such as ether and THF had a negative impact
on stereoselectivity [15]. On the other hand, recent studies de-
veloped by Sirvent and Foubelo demonstrated the influence of
the solvents in both the yield and diastereoselectivity in these
reactions. They found that working in THF led to higher yields
and poorer diastereoselectivities than when the reactions were
performed in less coordinating solvents, such as diethyl ether
and toluene [39].
Based on a broader analysis related to the effects of the solvent,
metal and additives in 1,2-addition reactions to N-tert-butane-
sulfinyl imines of organometallic compounds, different
transition models have been proposed to explain the stereo-
chemical outcomes. The cyclic model justified by the Zimmer-
mann–Traxler transition state [40-42] is the typical mechanism
operating in reactions involving Grignard reagents in noncoor-
dinating solvents, such as toluene and dichloromethane, while
an acyclic model [43] is common in organolithium compounds
in solvents such as THF. In the cyclic model, the bulky tert-
butyl group occupies an equatorial position due to steric
hindrance [1,14,44,45] (Scheme 5).
Other contributions to the nucleophilic addition reactions to
N-tert-butanesulfinyl imines were made by Yus and co-workers
employing organozincates [46-49] and indium [50].
After this brief about the synthesis of enantiomerically pure
N-tert-butanesulfonamide and applications in some nucleo-
philic additions, the next sections will describe the synthesis of
several alkaloids according to the size of the heterocycles. We
regret in advance that some contributions are excluded in order
to maintain a concise format.
Review
Asymmetric synthesis of aziridines
Saturated nitrogen-containing three-membered heterocycles
have attracted increasing interest in recent years because com-
pounds with this structural motif display quite diverse pharma-
cological activities. Chiral aziridines [51] also play an impor-
tant role in asymmetric synthesis because they can act both as
ligands [52-55] and as chiral auxiliaries [56]. The most widely
used synthetic methods to form the aziridine ring [57-61]
include intramolecular cyclizations in amines bearing potential
leaving groups. Stereoselective syntheses of aziridines have
been successfully carried out by combining a nucleophilic addi-
tion to N-tert-butanesulfinyl α-chloroimines, and an intramolec-
ular cyclization, the chlorine atom being finally displaced.
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
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Scheme 5: Transition models for the addition of organomagnesium and organolithium compounds to N-tert-butanesulfinyl imines.
Scheme 6: Synthesis of 2,2-dibromoaziridines 15 from aldimines 14 and bromoform, and proposed non-chelation-controlled transition state model.
Chiral N-tert-butanesulfinyl aldimines and ketimines have also
been used successfully to form aziridines through aza-Darzens
and Corey–Chaykovsky reactions [62,63].
The first asymmetric synthesis of 2,2-dibromoaziridines 15 was
achieved by performing the nucleophilic addition of the anion
resulting from the deprotonation of bromoform with sodium
hexamethyldisilazide (NaHMDS) to chiral N-tert-butane-
sulfinyl aldimines (RS)-14, at low temperature, and using DMF
as solvent. After addition, a subsequent intramolecular cycliza-
tion involving the resulting amide and the vicinal carbon with
bromine atoms took place. By contrary, when the reaction was
carried out in THF, the elimination process was suppressed,
leading exclusively to enantiomerically pure α-tribromomethyl-
amines 16. The structure and configuration of aziridines 15
were determined unambiguously by single crystal X-ray analy-
sis [64]. In order to explain the experimental results, a
nonchelation controlled transition state was proposed. Based on
computational studies, it is known that a kind of s-cis arrange-
ment of the sulfinyl group is the most stable conformation of
the imine, due to the contribution of the hydrogen bonding of
the oxygen and the iminic hydrogen. In this scenario, the tribro-
momethyl anion attacked the less hindered Re face of the imine
with (RS) configuration (Scheme 6).
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
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Scheme 7: Diastereoselective synthesis of aziridines from tert-butanesulfinyl imines.
The applicability of sulfinyl imines was also shown by Garcia
Ruano and co-workers. (SS)-tert-Butanesulfinyl imine 17b pro-
vided better diastereoselectivity to obtain aziridines 18b than
(SS)-tert-butanesulfinyl imine 17a to obtain aziridines 18a
(Scheme 7) [65].
Allylation of N-tert-butanesulfinyl imines 14 with allylic bro-
mides in the presence of zinc or indium metals is a well-known
reaction [66,67]. It is possible to control and predict the stereo-
chemistry of the addition to get the corresponding homoallyl-
amine derivative with a high level of stereocontrol. The reac-
tion of chiral imine 14 with an excess of 1,3-dibromopropene
(23) in THF at 50 °C for 2 h, and a 1000 rpm rotation speed, led
to trans-vinylaziridines 22, in moderate yields and high dia-
stereoselectivities. Those were the reaction conditions that Sun
and co-workers found to be optimal for the formation of the
vinylaziridines [68]. However, when the allylation was per-
formed in the presence of indium metal, in a saturated aqueous
solution of sodium bromide, a mixture of the bromoallylation
and allylation products 25 and 26, respectively, were obtained
[69]. The addition of the allyl unit to the imines proceeded with
total facial diastereoselectivity, producing also preferably dia-
stereoisomers with anti relative configuration. According to the
mechanism depicted on Scheme 8, the allyl unit reacted at γ-po-
sition, taking place the addition to the Si face of the imines with
RS configuration. The bromoallylated product 24 was obtained
as a mixture of anti/syn diastereoisomers. Treatment of com-
pounds 24 with potassium hexamethyldisilazide provided vinyl-
aziridines 22 through an intramolecular cyclization step. This
intramolecular nucleophilic substitution is a stereospecific
process. In the case of aromatic compounds 24, trans-vinyl-
aziridines were the only reaction products, meanwhile for ali-
phatic derivatives 24 (R = alkyl), trans- and cis-aziridines 22
were isolated in practically the same ratio as the anti/syn ratio of
their precursors 24. This shows that the cyclization reaction is
stereospecific (Scheme 8). Comparing both methodologies, the
indium-mediated bromoallylation seemed to be superior, since
aliphatic aldimines 14 were compatible with this approach.
The group of Stockman reported the synthesis of 2,2′,3-substi-
tuted aziridines 27 from N-tert-butanesulfinyl imines 14 and
α-bromoesters 26 by applying an aza-Darzens methodology
[70]. The reactions were performed in THF at −78 °C, using
lithium hexamethyldisilazide as base. Aziridines with relative
trans-configuration were obtained in good yields and excellent
stereoselectivities with methyl α-bromo-α-phenylacetate (26,
R2 = Ph). Lower yields, and poorer diastereoselectivities were
observed with less bulky methyl 2-bromo-2-butenoate
(R2 = CH3CH=), leading to an almost complete loss of cis/trans
selectivity by the reaction with aliphatic aldimines 14. The
absolute configuration of the reaction products was unambigu-
ously determined after X-ray crystallographic analysis of some
of the reaction products. In order to rationalize the observed
stereochemical outcome, a six-membered cyclic transition state
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
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Scheme 8: Synthesis of vinylaziridines 22 from aldimines 14 and 1,3-dibromopropene 23, and proposed chelation controlled transition state model.
Scheme 9: Synthesis of vinylaziridines 27 from aldimines 14 and α-bromoesters 26, and proposed transition state leading to the major diastereoiso-
mer.
has been proposed. The addition to imine 14 with SS configura-
tion takes place on the less hindered Re face, on the other hand,
the cis/trans selectivity observed being a consequence of the E
stereochemistry of both the imine 14 and the enolate derived
from bromoester 26 (Scheme 9).
A two-step protocol carried out in a single synthetic operation
was developed by Chen and Zhang to synthesize 3-substituted
2-chloroaziridines with relative cis configuration [71]. The reac-
tion of chiral imines 14 in dichloromethane in the presence of
2 equivalents of phenyllithium at −78 °C to room temperature
produced the expected 2-chloroaziridines with excellent yields
and diastereoselectivities. Under the previously commented op-
timized reaction conditions, dichloromethyllithium is first
generated, taking place a diastereoselective nucleophilic
dichloromethylation of the imine. The addition took place
almost exclusively to the Re face of the imine (RS)-14, which is
the less sterically hindered in the most stable s-cis conforma-
tion (see Scheme 2). The second intramolecular N-alkylation
step produced the 2-chloroaziridines 28 with relative cis config-
uration. The absolute proposed configurations were confirmed
by X-ray crystallographic analysis (Scheme 10).
An interesting asymmetric vinylogous aza-Darzens reaction was
employed to access cis-vinylaziridines 30 and 31. The group of
Njardarson found that the reaction of different aromatic and ali-
phatic chiral imines (SS)-14 with the dienolate resulting from
the deprotonation of bromomethyl butenolide 29 in THF at
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
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Scheme 10: Synthesis of 2-chloroaziridines 28 from aldimines 14 and dichloromethane, and proposed transition state model for the nucleophilic addi-
tion and for the elimination step.
Scheme 11: Synthesis of cis-vinylaziridines 30 and 31 from aldimines 14 and bromomethylbutenolide 29.
−78 °C led to a mixture of diastereomeric cis-vinylaziridines 30
and 31 with good yields in most cases. Lithium hexamethyldisi-
lazide was the base of choice to perform the deprotonation, and
it must be added very slowly to the reaction mixture in order to
suppress self-dimerization of the butenolide [72]. The struc-
tures as well as the absolute and relative stereochemistry of
reaction products 30 and 31 were also unambiguously deter-
mined following a single-crystal X-ray analysis (Scheme 11).
The stereoselective synthesis of diastereomeric 2-chloro-2-
aroylaziridines 36 and 32 was successfully accomplished
through a three-component cascade coupling reaction of
silyldichloro-methanes 33, arylnitriles 34 and chiral N-tert-
butanesulfinyl aldimines (RS)-14. The process reported by Lu,
Xu and co-workers started with the deprotonation of silyl com-
pounds 33 with LDA at –78 °C, leading to the corresponding
silyldichloromethyllium derivative, which reacted with arylni-
trile 34. After nucleophilic addition and [1,3]-aza-Brook rear-
rangement, N-silyllithiumenamide 35 was formed. This strongly
nucleophilic species could be traped by the chiral imine
(RS)-14, producing 2-chloro-2-aroylaziridines via and aza-
Darzens reaction [73]. Importantly, the structure of the final
aziridine is determined by the silyl group, and the order of the
addition of HMPA and imine 14 in the multicomponent cou-
pling. When the bulky TBS group was used, and HMPA was
added to the reaction mixture before the imine 14, aziridines 36
were formed. The addition of lithium metaloenamine took place
through and open transition state to the Re face of the imine
(RS)-14, followed by an intramolecular nucleophilic substitu-
tion to form the aziridines ring. On the contrary, aziridines 32
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
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Scheme 12: Synthesis of 2-chloro-2-aroylaziridines 36 and 32 from aldimines 14, arylnitriles 34, and silyldichloromethanes 33, and proposed transi-
tion states.
Scheme 13: Synthesis of trifluoromethylaziridines 39 and proposed transition state of the aziridination.
were obtained starting from dichloromethyltrimethylsilane (33,
[Si] = TMS), and adding the chiral imine before HMPA to the
reaction mixture. The nucleophilic addition of metaloenaime
occurred through a cyclic transition state to the Si face of the
imine (RS)-14. In this way, both cis-aziridines diastereoisomers
36 and 32 were formed from the same chiral imine 14 and aryl-
nitriles 34 (Scheme 12).
Chiral sulfinyl imines have been also used in the stereoselec-
tive synthesis of aziridines. The reaction of N-tert-butane-
sulfinyl trifluoromethyl ketimines (SS)-37 with dimethylsulfox-
onium methylide 38 gave trifluoromethylated aziridines 39 in
moderate to excellent yields (45–93%), and good diastereose-
lectivities (86:14 to >99:1 dr). The absolute configuration of
compounds 39 was determined by X-ray crystallographic analy-
sis, and it was found that the configuration of the newly gener-
ated stereocenter was R. Huang and co-workers proposed a
cyclic transition state determined by the coordination of the
nitrogen of the imine, and the oxygen atoms of the sulfoxonium
and sulfinyl units to the sodium cation, which is present in the
reaction medium [74]. The trifluoromethyl group occupies an
equatorial position to avoid electrostatic repulsion with the lone
pair of electrons of the sulfinyl group. The nucleophilic attack
took place to the Si face of the ketimine 37 (Scheme 13).
Recently, Yang and co-workers described the diastereoselec-
tive synthesis of aziridines 42 in one-step using the Cu(I)/ʟ-
proline complex as a catalyst and N-tert-butasulfinylamide in an
aminotrifluoromethylation reaction of alkenes. All the
aziridines 42 were obtained with high diastereoselectivity
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
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Scheme 14: Synthesis of aziridines 42 and proposed state transition.
Scheme 15: Synthesis of 1-substituted 2-azaspiro[3.3]heptanes, 1-phenyl-2-azaspiro[3.4]octane and 1-phenyl-2-azaspiro[3.5]nonane 45 from chiral
imines 14, and ethyl cycloalkanecarboxylates 43.
(dr > 25:1) and good yields (56–98%) from allylic sulfon-
amides 40 and Togni’s reagent (41). The reaction mechanism is
proposed based on DFT calculations. In this study, they ob-
served an intramolecularly intermediate Cu(III) species, and the
sulfinamide acts as a direction group and nucleophile [75]
(Scheme 14).
Asymmetric synthesis of azetidines
Azetidine [76,77] has attracted less attention than aziridines,
pyrrolidines and piperidines, among small and medium size
aza-heterocycles, because there are no general methods for their
preparation. However, four-membered nitrogen-containing
heterocycles have recently found applicability in pharmacy as
highly biological active compounds. Among this group of nitro-
genated heterocycles, β-lactams (azetidin-2-ones) have reached
especial attention [78-80], being easily accessible from
β-aminoesters.
A stereoselective synthesis of 1-substituted 2-azaspiro[3.3]hep-
tanes 45 (n = 1) was reported by the group of Reddy [81]
starting from ethyl cyclobutanecarboxylate 43 and chiral N-tert-
butanesulfinyl aldimines (RS)-14. In this three-step procedure, a
highly diastereoselective addition of the ethyl cyclobutanecar-
boxylate anion occurred first, followed by the reduction of the
ester group, and an intramolecular nucleophilic substitution of
the tosylate of the resulting primary alcohol (Scheme 15). This
methodology was applicable to the synthesis of 1-phenyl-2-
azaspiro[3.4]octane (45, n = 2, R = Ph) and 1-phenyl-2-
azaspiro[3.5]nonane (45, n = 3, R = Ph). The structure and
absolute stereochemistry of these compounds were assigned
based on the single-crystal X-ray diffraction analysis of
azaspiroheptane 45 with a 9-fenanthryl substituent at 1-position.
The same three-step procedure was applied by Reddy and
co-workers to synthesize 1-substituted 2,6-diazaspiro[3.3]hep-
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
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Scheme 16: Synthesis of 1-substituted 2,6-diazaspiro[3.3]heptanes 48 from chiral imines 14 and 1-Boc-azetidine-3-carboxylate (46).
Scheme 17: Synthesis of β-lactams 52 from chiral imines 14 and dimethyl malonate (49).
tanes 48, starting in this case from 1-Boc-azetidine-3-carboxyl-
ate 46, instead of ethyl cyclobutanecarboxylate 43 [82]. This
structural motif was found to have similar physicochemical
properties as 2-substituted piperazines, which are key interme-
diates in drug discovery. The applied protocol was found to be
practical for the asymmetric synthesis of a variety of aromatic,
heteroaromatic, and aliphatic 1-substituted 2,6-diaza-
spiro[3.3]heptanes 48, with overall yields ranging from 74 to
94% (Scheme 16).
Asymmetric synthesis of β–lactams
β-Lactam antibiotics are important drug class of antibacterial
agents [83] and in the literature, several strategies are reported
using the sulfinyl group [84-88]. In this context, an enantiose-
lective synthesis of 4-substituted azetidin-2-ones 52 was also
accomplished starting from chiral imines 14 and dimethyl
malonate (49). A diastereoselective coupling of these compo-
nents under solvent-free conditions was carried out, using sodi-
um carbonate as base promoter. The resulting dimethyl 2-(1-
aminoalkyl)malonates 50 were obtained in moderate to good
yields as single diastereoisomers in all cases except for aromat-
ic aldimines. Compounds 50 could be easily transformed
successively into β-amino esters 51, and the corresponding
β-lactams 52 with high optical purity (Scheme 17) [89]. The
absolute configurations of compounds 52 were obtained by the
comparison of the signs of specific rotation of 52 with
R = Ph(CH2)2, with that of known (R)-4-(2-phenylethyl)aze-
tidin-2-one. A 6/4-fused bicyclic transition state model was pro-
posed to rationalize the stereochemical outcome, in which the
sodium metal is chelated by the oxygen and the nitrogen atoms
of sulfinyl imine (Scheme 17), occurring the nucleophilic attack
to the Si face of the imines with RS configuration.
Su and Xu reported the stereoselective synthesis of spiro
β-lactam 57 from chiral (RS)-N-tert-butanesulfinyl isatin
ketimine 53 (R1 = H), with a bulky trityl protecting group
bonded to the nitrogen indolic atom (Tr = triphenylmethyl), and
ethyl bromoacetate. The Zn/Cu-mediated Reformatsky-type
reaction furnished enantiomerically pure compound 54 after
column chromatographic purification. Selective desulfinylation
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
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Scheme 18: Synthesis of spiro-β-lactam 57 from chiral (RS)-N-tert-butanesulfinyl isatin ketimine 53 and ethyl bromoacetate.
Scheme 19: Synthesis of β-lactam 60, a precursor of (−)-batzelladine D (61) and (−)-13-epi-batzelladine D (62) from chiral (SS)-N-tert-butanesulfinyl
imine 58, and antimicrobial evaluation of MCI values for these compounds.
of 54 was carried out by using 1.0 M HCl in EtOAc, and further
removal of the Tr group by the employment of TFA in dichloro-
methane afforded the 2-oxoindolinyl amino ester derivative 55,
the key intermediate for the synthesis of (–)-AG-041R, a
gastrin/cholecyctokinin-B receptor antagonist. In addition,
amino ester 55 was transformed into the fully unprotected
amino acid 56 under basic conditions in MeOH, and after that,
further treatment with of MsCl and NaHCO3 in MeCN at 80 °C
led to spiro-β-lactam derivative 57 in 72% combined yield
(Scheme 18) [88].
In 2020, Pierce and co-workers developed a method for the syn-
thesis of guanidinium alkaloid batzelladine D in enantiomeric
and racemic form, along with a series of stereochemical ana-
logues. The batzelladines are a family of polycyclic guani-
dinium alkaloids that were isolated in the mid-1990s from the
Caribbean sponge bataella sp. From a biological point of view,
the batzelladines have received attention due to their reported
activity as inhibitors of HIV gp120-human CD4 binding. Chiral
N-tert-butanesulfinyl aldimine (SS)-58 was used as a precursor
in the synthesis of (–)-batzelladine D 61 and (–)-13-epi-batzel-
ladine D 62. The reaction of (SS)-58 with methyl bromoacetate
in the presence on Zn and CuCl in THF, left, after removal of
the sulfinyl group under acidic conditions, to β-amino ester am-
monium chloride 59 in high yield. This compound was trans-
formed into β-lactam 60 in 90% yield by treatment with LDA in
THF at −78 °C [90]. Compound 60 was converted after 9 steps
in target batzelladines D 61 and 62 (Scheme 19). The authors
explored also the antimicrobial activity of these compounds
against a series of pathogens with starting promising results.
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
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Scheme 20: Rhodium-catalyzed asymmetric synthesis of 3-substituted pyrrolidines 66 from chiral imine (RS)-63 and sodium tetraarylborates 64.
Scheme 21: Asymmetric synthesis of 1,3-disubstituted isoindolines 69 and 70 from chiral imine 67.
Asymmetric synthesis of pyrrolidines
The pyrrolidine ring is more represented within natural prod-
ucts than the 3- and 4-membered nitrogen-containing hetero-
cycles. This molecular array is also found in drugs and other bi-
ologically active molecules. For this reason, there are numer-
ous examples of synthetic methodologies for these compounds
in the literature. In most cases, the pyrrolidine ring is formed
from an amine with a hydrocarbon chain that also carries a
functional group at the appropriate distance that allows the
cyclization process to take place. In the case of substituted
pyrrolidines, the stereoselective synthesis is especially interest-
ing, highlighting the 1,3-dipolar cycloaddition reactions with
azomethine ylides as an example of transformation that take
place with great stereocontrol, and allow the synthesis of poly-
functionalized pyrrolidines in a single reaction step [91,92]. On
the other hand, natural amino acids proline and hydroxyproline
are functionalized pyrrolidines that have found great applica-
tion in organic synthesis as chiral organocatalysts in stereose-
lective processes [93,94].
Cyclizations involving a position in the starting chiral
imine
Arylation of chiral sulfinyl imines with sodium tetraaryl-
boronates 64 was found to proceed with high diastereoselectiv-
ity under rhodium catalysis. Reddy and co-workers applied this
methodology to the synthesis of 2-substituted pyrrolidines 66
[95]. The arylation of chlorinated imine (RS)-63 was performed
with 2 mol % of an air-stable rhodium catalyst in dioxane, in
the presence of 2 equivalents of MeOH, at 65 °C, leading to
compounds 65 with high diastereomeric ratio. Crude amides 65
were converted into the corresponding pyrrolidines 66 in high
yield by stirring at room temperature for 1 h in presence of
2.0 equivalents of LiHMDS (Scheme 20). It is important to
highlight that cyclization occurred without epimerization with
such as strong base.
Isoindolines with substituents at 1 and 3 positions were synthe-
sized from an aromatic N-tert-butanesulfinyl imine 67, bearing
a Michael acceptor in the ortho-position. Fustero, Barrio and
co-workers found that combining an asymmetric nucleophilic
addition to the chiral imine, with an intramolecular conjugate
aza-Michael reaction, the expected 1,3-disubstituted isoindo-
lines were produced with high diastereoselectivity [96]. Impor-
tantly, depending on the base involved in the intramolecular
aza-Michael reaction, it was possible to reach either cis- or
trans-isoindolines, 69 and 70, respectively, from the same pre-
cursor 68. The authors proposed that the thermodynamically
more stable cis-isomer 69 is formed when TBAF was used.
Meanwhile, working under kinetic conditions (DBU as base),
trans-isomer 70 was obtained (Scheme 21).
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Scheme 22: Asymmetric synthesis of cis-2,5-disubstituted pyrrolidines 73 from chiral imine (RS)-71.
Scheme 23: Asymmetric synthesis of 3-hydroxy-5-substituted pyrrolidin-2-ones 77 from chiral imine (RS)-74.
The group of Stahl provided an elegant approach to the synthe-
sis of 2,5-disubstituted pyrrolidines 73, from alkenyl sulfi-
namides 72 [97]. These substrates were prepared from chiral
N-tert-butanesulfinyl imine (RS)-71. Nucleophilic additions to
this imine took place with high diastereoselectivity to the Si
face of the iminic carbon. After that, the combination of
Pd(TFA)2, lithium acetate and DMSO as solvent led to optimal
results in the oxidative cyclization process to produce pyrrol-
idines 73 as a single diastereoisomer, with relative cis-configu-
ration (Scheme 22). This has been the first reported nucleo-
philic attack of the sulfinyl group to a π-allylpalladium interme-
diate.
The asymmetric synthesis of 3-hydroxy-5-substituted pyrro-
lidin-2-ones 77, with relative cis-configuration, was reported by
the group of Huang and Wei [98]. A diastereoselective addition
of Grignard reagents to chiral aldimine (RS)-74, and an intramo-
lecular oxidative cyclization of aminoalcohols derivatives 76,
are key steps of this approach. Both diastereoisomers of
aldimines 74 (RS and SS) were prepared from ᴅ-malic acid and
the corresponding enantiomer of tert-butanesulfinamide. Impor-
tantly, the choice of the solvent was crucial for obtaining high
diastereoselectivities in the Grignard addition step, in which
dichloromethane was performing better than THF. On the other
hand, diastereoselectivities for addition products 75 were higher
working with (RS)-74 than its (SS) diastereoisomer, indicating a
mismatch between the chiral auxiliary and the stereocenter in
this substrate. Concerning the oxidative cyclization reaction,
pyridinium dichromate (PDC) provided low yields of expected
lactam 77. Many oxidants were checked for this transformation
to take place, and the Sarett reagent [CrO3·(C5H5)2] in DMF
was the best to produce lactams 77. The synthetic interest of
these functionalized lactams was demonstrated in the synthesis
of alkaloid (−)-preussin (78) from the appropriate precursor 77
in three steps (Scheme 23).
Similar strategies were employed to obtain similar heterocycles
[99]. Other regio- and stereoisomeric 2-pyrrolidones 80 were
also prepared by a stereoselective tandem Barbier process of 79
with alkyl and aryl bromide [100]. The process was performed
in this case under Barbier reaction conditions. Namely, the for-
mation of the nucleophile (organomagnesium reagent) is carried
out in the presence of the electrophile (chiral imine 79). Surpris-
ingly, both diastereomeric aldimines 79 (RS and SS) gave simi-
lar results concerning the stereochemical outcome, suggesting
that the chiral sulfonamide moiety was not involved in the
stereocontrol during this tandem Barbier addition process. After
addition of the organomagnesium reagent to the imine 79, cycli-
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Scheme 24: Asymmetric synthesis of 4-hydroxy-5-substituted pyrrolidin-2-ones 80 from chiral imines 79.
Scheme 25: Asymmetric synthesis of 3-pyrrolines 82 from chiral imines 14 and ethyl 4-bromocrotonate (81).
zation involving the magnesium amide and the ester occurred
without the need of an extra cyclization step to give, after
N-Boc protection, 4-hydroxy-5-substituted pyrrolidin-2-ones
90, with relative trans-configuration (Scheme 24).
Cyclizations involving a position in the attacking
nucleophile
The reaction of ethyl 4-bromocrotonate (81) with LDA at
−78 °C and subsequent addition of chiral imines 14 afforded
3-pyrrolines 82 with high diastereoselectivity. Chogii and Njar-
darson proposed that after deprotonation of 81, the resulting
dienolate reacted at α-position with the chiral imine 14. The ad-
dition was highly diastereoselective, being the configuration of
the newly created stereogenic center dependent on the configu-
ration of the sulfur atom of the starting imine 14. After nucleo-
philic addition, and subsequent elimination, 3-pyrrolines 82
were formed as single diastereomers [101]. The whole process
could be considered a [3 + 2] annulation, and aziridines were
not observed as competing reaction products (see above
Scheme 11). In addition, hindered imines, ethers, sulfonates,
heteroaryl substituents, and conjugated imines were all well
tolerated (Scheme 25).
A SmI2-mediated coupling of allenoate 83 with chiral (RS)-14
provided γ-amino ester derivatives 84 in good yields and mod-
erate diastereomeric ratios. Huang and Py found that the better
yields and diastereoselectivities were found working in THF as
solvent in the presence of t-BuOH and LiBr as additives [102].
The isopropyl-substituted derivative 84 was easily converted
into the corresponding methylene lactam 85, upon removal of
the sulfinyl unit under acidic conditions. Finally, ozonolysis of
85 yielded tetramic acid 86 in 60% yield (Scheme 26). The con-
figuration of the newly generated chiral center in compounds 84
was assigned from the sign of the optical rotation of enantio-
enriched tetramic acid 86, which was previously characterized.
Based on this, it can be stated that addition of the allenoate 83
takes place mainly to the Re face of imines with (RS)-configura-
tion.
Excellent diastereoselectivities were also achieved in the
indium-mediated allylation of chiral tert-butanesulfinyl glyoxy-
late imine derivatives 87 with ethyl 2-bromomethylacrylate
(88). Working at room temperature without any additional sol-
vent provided the highest yields in these coupling reactions,
amino diesters 89 being isolated as single diastereoisomers
(Scheme 27). Removal of the sulfinyl group under acidic condi-
tions, and further treatment of the resulting ammonium salts
with sodium ethoxide, yielded α-methylene-γ-butyrolactams 90,
in a one-pot, two-step process [103]. A six-membered chair-like
transition state model with the indium coordinated to the
nitrogen atom of the imine, and the sulfinyl and R groups
located at axial positions, in a kind of s-cis conformation,
was proposed to rationalize the stereochemical outcome. By
considering this working model, the nucleophilic attack took
place to the Re face of imines with (Z,SS)-configuration
(Scheme 27).
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Scheme 26: Asymmetric synthesis of γ-amino esters 84, and tetramic acid derivative 86 from chiral imines (RS)-14 and allenoate 83.
Scheme 27: Asymmetric synthesis of α-methylene-γ-butyrolactams 90 from chiral imines (Z,SS)-87 and ethyl 2-bromomethylacrylate 88.
The cycloaddition of chiral sulfinyl imines (RS)-14 with
2-(trimethysilylmethyl)allyl acetate (91) could also be promoted
by Pd(0) to give methylenepyrrolidines 92. The group of
Stockman demonstrated that Pd(PPh3)4 was the best source of
Pd(0) and that the reaction worked well in different solvents,
with dry THF giving the best diastereoselectivities and good
yields at room temperature [104]. The configuration of the
major diastereoisomer was assigned by X-ray crystallographic
analysis. From this, authors rationalized the stereochemical
outcome of the cyclization considering that the stereoinduction
is derived from the dipole–dipole repulsion of the sulfinyl
imine, which places the tert-butyl group on the Si face, and thus
the cycloaddition occurs from the less sterically hindered Re
face. The cyclization process worked also in tert-butanesulfinyl
ketimines, but yields and diastereoselectivities were significant-
ly lower (Scheme 28).
Recently, a series of alkaloids like dibenzoazaspirodecanes 97
have been synthesized by addition of 2-bromobenzylmagne-
sium bromide (94) to chiral N-tert-butanesulfinyl imines 93.
These reactions proceeded with high levels of diastereocontrol.
The resulting sulfonamide derivatives 95 were transformed into
the target spiro compound 97 by performing successive
desulfinylation and intramolecular palladium-catalyzed N-aryl-
ation. To rationalize the stereochemical course of the addition,
DFT calculations were performed and they predicted correctly
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Scheme 28: Asymmetric synthesis of methylenepyrrolidines 92 from chiral imines (RS)-14 and 2-(trimethysilylmethyl)allyl acetate 91.
Scheme 29: Synthesis of dibenzoazaspirodecanes from cyclic N-tert-butanesulfinyl imines.
the observed experimental results considering a six-membered
ring cyclic transition state. The addition took place to the
Si-face of the imines with (RS)-configuration. Compounds 97
were also evaluated in a preliminary study in leukemia strains
(Scheme 29) [105].
Li and Xu reported a method for the enantioselective synthesis
of β,γ-unsaturated α-amino acids 100, by a Lewis acid-
promoted diastereoselective Petasis reaction of vinylboronic
acids 98, (R)-N-tert-butanesulfinamide and glyoxylic acid (99).
They found that the best results were obtained working with
InBr3 as Lewis acid, in dichloromethane at room temperature
[106]. Under these reaction conditions, sulfinyl imine is formed
first along with the boronate by interaction of the correspond-
ing vinylboronic acid with the carboxylic group of the imino
acid intermediate. The transfer of the vinyl unit to the electro-
philic iminic carbon took place in a quite rigid system, with
chelation of the Lewis acid with the nitrogen of the imine and
carboxylate oxygen, forming a five-membered ring. The migra-
tion of the vinyl group occurred to the Re face of the imine,
which is less shielded than the Si face, because of the influence
of the bulky tert-butyl in the most stable conformation of the
sulfinyl imine (Scheme 30). The authors also demonstrated the
synthetic utility of compounds 100. Their reaction with thionyl
chloride in methanol produced removal of the sulfinyl group
and formation of the corresponding methyl ester, to give com-
pounds 101. Subsequent, reductive ammination with 3-phenyl-
2-propynal led to reaction intermediates 102, which under
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Scheme 30: Stereoselective synthesis of cyclopenta[c]proline derivatives 103 from β,γ-unsaturated α-amino acids 100.
typical Pauson–Khand reaction conditions gave cyclo-
penta[c]proline derivatives 103 in moderate yields, with high
diastereoselectivities (Scheme 30).
Asymmetric synthesis of piperidines
The six-membered nitrogen-containing rings are the most
common heterocycles among natural products and also synthe-
tic pharmaceutical drugs [107,108]. For this reason, the piperi-
dine unit has attracted great attention among organic chemists
[109]. Due to that, a large number of classical methodologies
have been used for their synthesis, in which the key step is the
generation of the six-membered ring, including the aldol reac-
tion, the reductive amination, Mannich reaction, ring closing
metathesis, Diels–Alder reaction with imines as dienophiles,
aza-Prins cyclization, and intramolecular Michael reaction,
among others [110-115]. Despite the considerable effort made
to date in this field, the development of new methodologies that
allow accessing these heterocycles in a stereoselective way, and
taking into account environmental considerations as one of the
most important points, continue to be of great interest [109,116-
118].
Cyclizations involving a position in the starting chiral
imine
Enantiomeric N-tert-butanesulfinyl imines 104b derived from
3-(2-bromophenyl)propanal have been used as reaction interme-
diates in the synthesis of tetrahydroquinoline alkaloids
(−)-angustureine (107) and (−)-cuspareine (108) reported by
Sirvent et al. [119]. The diastereoselective addition of a Grig-
nard reagent was a key step in this methodology. The addition
proceeded with high diastereoselectivity in toluene, and the
attack of the Grignard reagent occurred on the Re face of the
imine with S configuration at the sulfur atom, through a
chelated transition state. The reaction of chiral aldimine
(SS)-104b with pentylmagnesium bromide gave compound 106
in 75% yield. Further successive N-desulfinylation, intramolec-
ular palladium-catalyzed N-arylation, and final N-methylation
led to (−)-angustureine (107) in high overall yield (Scheme 31).
The same methodology was applied to the synthesis of
(−)-cuspareine (108), starting in this case from enantiomeric
imine (RS)-104b, and using 2-(3,4-dimethoxyphenyl)ethylmag-
nesium bromide as Grignard reagent.
A straightforward synthesis of the alkaloid (−)-pelletierine
(112) was accomplished by the diastereoselectivity coupling of
3-oxobutanoic acid (110) and the N-tert-butanesulfinyl imine
(RS)-109 derived from 5-bromopentanal (114). The base-
promoted decarboxylative-Mannich coupling of these reagents
led to β-amino ketone derivative 111, which was not isolated.
After removal of the sulfinyl group under acidic conditions, and
intramolecular N-alkylation upon treatment with sodium bicar-
bonate, (−)-pelletierine (112) was formed, and easily isolated as
its hydrochloride derivative (Scheme 32) [120]. Compound 112
is a key intermediate in the biomimetic synthesis of natural
alkaloids. Interestingly, amino allylation of 5-bromopentanal
(114) with (R)-tert-butanesulfinamide and allyl bromide (113,
R = H) in the presence of indium metal gave homoallylamine
derivative 115. In this transformation, imine (RS)-109 is a reac-
tion intermediate that was not isolated. Treatment of 115 with
potassium hexamethyldisilazide (KHMDS) led to the sulfinyl
piperidine derivative 116, and final deprotection under acidic
conditions produced enantioenriched 2-allylpiperidine (117) as
its hydrochloride (Scheme 32) [121]. Compound 117 has been
also an advanced intermediate in the synthesis of alkaloids. For
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Scheme 31: Stereoselective synthesis of alkaloids (−)-angustureine (107) and (−)-cuspareine (108).
Scheme 32: Stereoselective synthesis of alkaloids (−)-pelletierine (112) and (+)-coniine (117).
instance, hydrogenation of 117 yielded (+)-coniine (118), the
major alkaloid extracted from poison hemlock and responsible
for its toxicity, as its hydrochloride, and N-Boc protected deriv-
ative of 117 submitted to Wacker oxidation led to (−)-
pelletierine (112) alkaloid.
Yus and co-workers developed the synthesis of the piperidine
alkaloids (+)-dihydropinidine (122a), (+)-isosolenopsin (122b),
(+)-isosolenopsin A (122c) and (2R,6R)-6-methylpipecolic acid
hydrochloride by oxidation of the aromatic ring of (2R,6R)-2-
methyl-6-phenylpiperidine (122d). The diastereoselective ally-
lation of (SS)-N-tert-butanesulfinyl imines 119 mediated by
indium metal under Barbier's reaction connections (formation of
the allylindium intermediate in the presence of the imine elec-
trophile) is the key step in these syntheses (Re-face attack). The
natural products were obtained after four additional steps: cross-
metathesis of allylated compounds 120 with methyl vinyl ke-
tone, reduction of conjugated C=C double bond, removal of the
sulfinyl group under acidic conditions, and final stereoselective
reduction of the imine formed by intramolecular cyclization
(Scheme 33) [122].
The group of Prasad reported the diastereoselective synthesis of
β-amino ketone derivatives from N-tert-butanesulfinyl imines
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
1115
Scheme 33: Synthesis of piperidine alkaloids (+)-dihydropinidine (122a), (+)-isosolenopsin (122b) and (+)-isosolenopsin A (122c) .
Scheme 34: Stereoselective synthesis of the alkaloids(+)-sedamine (125) from chiral imine (SS)-119.
and silyl enol ethers of aryl methyl ketone [123]. The synthetic
interest in β-amino ketones was exemplified in the synthesis of
alkaloid (+)-sedamine (125), which has been shown to display
memory-enhancing properties and was also effective for the
treatment of cognitive disorders. The reaction of the N-tert-
butanesulfinyl imine (SS)-119 with trimethylsilyl enol ether
derived from acetophenone 123 in the presence of TMSOTf at
low temperature, produced β-amino ketone derivative 124 in
high yield and diastereoselectivity (Scheme 34). A reduction of
124 gave a mixture of diastereomeric alcohols, and the one with
(R)-configuration at the benzylic position was isolated in 54%
yield. Further treatment of the alcohol with NaH furnished a
cyclized product, which after desulfination and N-methylation
led to expected (+)-sedamine (125) in 30% overall yield from
ketone derivative 124.
The stereoselective synthesis of trans-5-hydroxy-6-substituted-
2-piperidinones was also reported by the group of Wei, taking
advantage of the addition of Grignard reagents to N-tert-butane-
sulfinyl α-alkoxy aldimines 126 [124]. In this one-pot approach,
a successive nucleophilic addition–cyclization–desulfinylation
took place, leading directly to piperidinones 127. The reactions
were performed in THF at −78 °C for 3 hours. Yields ranged
from moderate to excellent with aliphatic and aromatic organo-
magnesium compounds. Based on X-ray crystallographic
analyses, the relative configurations of the products 127 were
unambiguously assigned as trans-form. The stereocontrol was
governed by the stereogenic center bearing the OTBS group at
α-position of the imine, showing no influence on it the configu-
ration of the sulfur atom of the sulfinyl unit. This methodology
was applied to the asymmetric synthesis of (−)-CP-99,994
(128), the enantiomer of a promising clinical agent which
displays a variety of biological activities, including neurogenic
inflammation, pain transmission, and regulation of the immune
response. Starting from α-alkoxy aldimines ent-126, the utility
of this methodology was also demonstrated in the synthesis of
alkaloid (+)-cassine (130), isolated from the leaves and twigs of
Cassia excelsa, displaying antimicrobial activity. Methylmag-
nesium bromide was the Grignard reagent in this synthesis, with
a 18% overall yield after seven steps from aldimine ent-126
(Scheme 35) [125].
The reaction of chiral α-siloxyl imine (SS)-126 with enolates
derived from methyl ketones 131 was also investigated. The
enolate was formed with LDA at −78 °C and reacted at the
same temperature with imine (SS)-126 for 2.5 hours. The addi-
tion proceeded with high diastereoselectivity, followed by cycli-
zation. Final acid treatment produced the removal of the sulfinyl
group leading to trans-5-hydroxy-6-substituted ethanone-2-
piperidinones 132 in moderate to high yields, as a single dia-
stereoisomer [126]. The diastereoselectivity of the addition was
controlled in this case by both the α-siloxyl group and the chiral
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Scheme 35: Stereoselective synthesis of trans-5-hydroxy-6-substituted-2-piperidinones 127 and 129 from chiral imines 126.
Scheme 36: Stereoselective synthesis of trans-5-hydroxy-6-substituted ethanone-2-piperidinones 132 from chiral imine (SS)-126.
sulfinamide moiety. Interestingly, the utility of this approach
was also demonstrated by the synthesis of (+)-febrifugine (133),
a natural product isolated from Chinese medicinal plants
Dichroa febrifuga Lour., and (+)-halofuginone (134), which is a
pharmaceutical candidate developed from febrifugine for the
treatment of human scleroderma (Scheme 36).
The reaction of chiral imine 135 with Grignard reagents in THF
took also place with high diastereoselectivity. Starting imine
135 with two well-defined stereogenic centers at the hydro-
carbon backbone were prepared as a mixture of (RS)- and (SS)-
diastereoisomers from ᴅ-glutamic acid. After nucleophilic addi-
tion to the imine, a successive cyclization–desulfinylation
occurred to give the corresponding piperidinone. Final reaction
with di-tert-butyl dicarbonate led to functionalized 2-piperidi-
nones 136 [127]. These compounds are interesting reaction
intermediates because they can be transformed by conventional
reactions into, for instance, compound L-685,458 (137), an in-
hibitor of γ-secretase, with potential interest for the treatment of
Alzheimer’s disease and other neurological disorders
(Scheme 37).
The diastereoselective synthesis of trans-5-hydroxy-6-substi-
tuted 2-piperidinones 139 was also achieved from O-benzyl
protected aldimine 138 following the previously commented
tandem Grignard reagent addition, subsequent cyclization-
desulfinylation, and final N-Boc protection. The stereochemical
pathway is controlled exclusively again by the configuration of
the stereogenic center bearing the benzyloxy group [128]. Inter-
estingly, chiral δ-lactams 139 are synthetic intermediates that
can be transformed into compound (+)-L-733,060 (140), a
potent neurokinin substance P receptor antagonist. This
compound displays a wide variety of biological activities,
including inhibition of neurogenic inflammation, blocking
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Scheme 37: Stereoselective synthesis of trans-3-benzyl-5-hydroxy-6-substituted-2-piperidinones 136 from chiral imines 137.
Scheme 38: Stereoselective synthesis of trans-5-hydroxy-6-substituted 2-piperidinones 139 from chiral imine 138.
Scheme 39: Stereoselective synthesis of ʟ-hydroxypipecolic acid 145 from chiral imine 144.
of pain transmission and regulation of immune response
(Scheme 38).
A stereoselective synthesis of ʟ-hydroxypipecolic acid 145 was
reported recently by Zhang and Sun. Compound 145 is an inter-
mediate for the synthesis of β-lactamase inhibitors. A key step
in this synthesis was the hydrocyanation of chiral sulfinyl imine
141, prepared from commercially available and inexpensive
ʟ-glyceraldehyde acetal, with trimethylsilyl cyanide (TMSCN)
in THF at −10 °C. The reaction product 142 was obtained in
quantitative yield and good diastereomeric ratio. Further hydro-
lysis of the cyclic acetal, and subsequent epoxidation of the re-
sulting diol under typical Mitsunobu conditions led to epoxide
derivative 143. The piperidine ring was formed through a
6-endo-tet cyclization by treatment of the epoxide 143 with so-
dium carbonate in toluene at 80 °C. Hydrolysis of the cyano
group under acidic conditions of compound 144 led to expected
ʟ-hydroxypipecolic acid hydrochloride 145 in high yield
(Scheme 39) [129].
In 2018, Wei and co-workers described the diastereoselective
synthesis of 1-substituted isoquinolones using one-pot
addition–cyclization–deprotection of the imine with Grignard
reagents [130]. In this work, the addition to chiral imines 146,
148 and 150 was performed using 2,2’-dipyridyl- or 4-methyl-
morpholine (NMM) to promote the complexation with the Grig-
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Scheme 40: Synthesis of 1-substituted isoquinolones 147, 149 and 151.
nard reagent. Products 147 and 149 were obtained in excellent
yields and high diastereoselectivity and when 4-methylmorpho-
line (NMM) was used as additive, the heterocycle 151 was ob-
tained in one pot addition–cyclization–deprotection of imine
150 (Scheme 40).
In 2020, Kaczorek and Kawęcki described the stereoselective
synthesis of 3-substituted dihydrobenzo[de]isoquinolones 154
in both enantiomeric forms in one step. In this study, they re-
ported an addition–cyclization–substitution reaction employing
(Rs) and (Ss) N-tert-butylsulfinyl imine 14 and Grignard
reagents using THF or CH2Cl2 as solvent at 40 °C. The
3-substituted dihydrobenzo[de]isoquinolinones 154 were ob-
tained with good yield and with enantiomeric excess of
46–99%. The mechanism was explained by stereoselective ad-
dition of the Grignard reagent to the N-sulfinyl imine 153a
derived from 152, in a subsequent cyclization to obtain the
intermediate 156 then, a substitution at the sulfur atom occurred
to form 154a and 157 [131] (Scheme 41).
In 2017, Reddy and co-workers described the stereoselective
synthesis of (S)-1-benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroiso-
quinoline (163), (S)-1-benzyl-6,7-dimethoxy-N-methyl-1,2,3,4-
tetrahydroisoquinoline (164), (−)-O,O-dimethylcoclaurine (165)
and (+)-O-methylarmapavine (166) alkaloids via chiral tert-
butylsulfinamide through a haloamide cyclization. The strategy
was based on the addition of organomagnesium bromide or
chloride to chiral N-sulfinyl imine 160. A subsequent base
promoted cyclization of chloroamides (158 and 162) and the
products 165 and 163 were obtained in 91% and 93% yields re-
spectively. The N-methylation of alkaloids 163 and 165 using
37% formaldehyde and sodium borohydride formed the tetra-
hydroisoquinoline 164 and 166 in high yields of 95% and 94%,
respectively [132] (Scheme 42).
Pinto and co-workers reported recently the enantioselective syn-
thesis of natural alkaloids (−)-cermizine B 171 and (+)-serrate-
zomine E 172. A key step of the synthetic strategy is the allyla-
tion with allylmagnesium bromide of N-tert-butanesulfinyl
imine 168. At the allylation step, a new chiral center with S con-
figuration in compound 169 is formed in 96% yield. After
removal the chiral sulfinyl group under acid conditions, treat-
ment with acryloyl chloride produced acrylamide derivative
170. From this common intermediate, and after several subse-
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Scheme 41: Stereoselective synthesis of 3-substituted dihydrobenzo[de]isoquinolinones 154.
quent steps, including ring-closing metathesis [133],
(−)-cermizine B (171) and (+)-serratezomine E (172) were ob-
tained 57% and 72% yield, respectively (Scheme 43) [134,135].
Cyclizations involving a position in the attacking
nucleophile
Isosolenopsin (177) and solenopsin (178) are two isomeric pi-
peridine alkaloids isolated from fire ants (Solenopsis) and
display hemolytic, insecticide and antibiotic properties. A
straightforward synthesis of these natural products from a
common imine intermediate was reported by Medjahdi et al.
comprising as key steps the indium–titanium-mediated aminoal-
lylation of nonanal with (R)-tert-butanesulfinamide and allyl
bromide, giving rise homoallylamine derivative 173, a subse-
quent cross metathesis with methyl vinyl ketone (174) cata-
lyzed by Hoveyda–Grubbs second generation catalyst to
produce compound 175, followed by hydrogenation–desulfyna-
tion, and final stereoselective reduction of the resulting cyclic
imine intermediate 176. In this diastereodivergent approach,
reduction of this imine with sodium borohydride in a citrate-
phosphate buffer medium (pH 5) led to (+)-isosolenopsin (177)
in 93% yield and >98:2 cis/trans selectivity. On the other hand,
when the reduction of imine 177 was carried out applying H.
Yamamoto’s protocol (AlMe3/LiAlH4), (+)-solenopsin (178)
was isolated in 83% yield and with excellent diastereoselectiv-
ity (>98:2 trans/cis selectivity, Scheme 44) [136].
There are many compounds with a 1,2,3,4-tetrahydroiso-
quinoline structural motif bearing substituents at 1-position
which display a wide range of biological activities. However,
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Scheme 42: Enantioselective synthesis of alkaloids (S)-1-benzyl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline (163), (S)-1-benzyl-6,7-dimethoxy-N-
methyl-1,2,3,4-tetrahydroisoquinoline (164), (−)-O,O-dimethylcoclaurine (165) and (+)-O-methylarmapavine (166).
Scheme 43: Enantioselective synthesis of alkaloids (−)-cermizine B (171) and (+)-serratezomine E (172) developed by Pinto and co-workers.
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Scheme 44: Stereoselective synthesis of (+)-isosolepnosin (177) and (+)-solepnosin (178) from homoallylamine derivative 173.
compounds bearing substituents at 3-position are less repre-
sented in nature and among pharmaceutical drugs. A multistep
methodology to synthesize 1,2,3,4-tetrahydrosioquinolines 185
bearing substituents at 3-, 6- and 7-positions in a highly enan-
tioselective fashion starting from chiral N-tert-butanesulfinyl
imines (RS)-14 was reported by Sirvent et al. [137]. The key
step of this synthesis is a [2 + 2 + 2] cyclotrimerization by
means of Wilkinson catalyst of azadiyne system 180, which was
accessible from imine 14 by consecutive diastereoselective
indium-promoted propargylation, selective N-propargylation
and final oxidation of the sulfinyl group. Sulfinyl imines
(RS)-14 could be also precursors of tetrahydroisoquinolines
with substituents at different positions of the aromatic ring, by
combining allylation and propargylation processes as the first
steps of this new strategy. The resulting azaenynes 179 and 181
were efficiently transformed by a ruthenium-catalyzed ring-
closing metathesis into cyclic 1,3-dienes 182 and 186, respec-
tively. The best results were obtained by performing the metath-
esis with Hoveyda–Grubbs second generation catalyst in the
synthesis of cyclodiene 182, and with Grubbs first generation
catalyst for compound 186. When these dienes reacted with
dimethyl acetylenedicarboxylate in toluene at 100 ºC, followed
by dehydrogenation of the resulting [4 + 2] adduct with DDQ,
the expected 7,8- or 5,6-bis(methoxycarbonyl)substituted
1,2,3,4-tetrahydrosioquinolines 184 and 187, were obtained, re-
spectively (Scheme 45).
Many indole alkaloids have been known for years and used in
ancient cultures as psychotropic, stimulants and poisons. On the
other hand, benzofurans and indoles, with a 2-aminoalkyl sub-
stituent at the 2-position, are not common compounds nor are
they represented in nature. For that reason, synthetic methodol-
ogies to access these systems are of interest in order to explore
their biological activity. Homopropargylamine derivatives 188
were obtained in a highly diastereoselective fashion (>95:5 dr)
by nucleophilic addition of allenylindium intermediate to chiral
N-tert-butanesulfinyl imines 14. Subsequent Sonogashira cou-
pling of compounds 188 with o-iodophenol (X = O) or
o-iodoaniline (X = NH) 189, led to 2-(2-aminoalkyl)benzo-
furan (X = O) and -indole (X = NH) derivatives 191. Further
removal of the sulfinyl unit under acidic conditions produced
amine derivatives 192, which were transformed into tetrahy-
dropyrido-benzofuran (X = O) and indole (X = NH) derivatives
193 with relative cis-configuration, upon reaction with alde-
hydes. This Pictet–Spengler condensation was facilitated by the
nucleophilic character of the 3-position of the benzofuran or
indole moiety (Scheme 46) [138].
Turlington and co-workers reported a stereoselective synthesis
in three steps of 2-substituted 1,2,5,6-tetrahydropyridines 196
starting from chiral N-tert-butanesulfinyl imines (RS)-14 [139].
The synthesis commenced with addition of the organolithium
compound resulting from the deprotonation of 4-chloro-1-
butyne (194) to the imine. The propargylamine derivatives 195
were obtained in high yields and diastereoselectivities
(>20:1 dr, in most cases). The lowest diastereoselectivity was
found for pyridyl-substituted imine 14 (R = 3-pyridyl, 4:1 dr),
due probably to competitive coordination of the lithium
acetylide by the heteroatoms present in these imines. Reduction
of the triple bond with Lindlar catalyst to provide olefin with
cis-configuration, and cyclization using LiHMDS led to 1,2,5,6-
tetrahydropyridines 196 (Scheme 47).
Many methods have been provided to generate thermodynami-
cally stable cis-2,6-disubstituted piperidines, but the synthesis
of trans-derivatives remains elusive. In this regard, Bhat-
tacharjee and co-workers reported a highly efficient large-scale
synthesis of 2,6-trans-piperidine derivative 199 from easily
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
1122
Scheme 45: Stereoselective synthesis of tetrahydroquinoline derivatives 184, 185 and 187 from chiral imines (RS)-14.
Scheme 46: Stereoselective synthesis of pyridobenzofuran and pyridoindole derivatives 193 from homopropargylamine derivatives 192.
Scheme 47: Stereoselective synthesis of 2-substituted 1,2,5,6-tetrahydropyridines 196 from chiral imines (RS)-14.
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Scheme 48: Stereoselective synthesis of 2-substituted trans-2,6-disubstituted piperidine 199 from chiral imines (SS)-14 (R = 4-BrC6H4).
Scheme 49: Stereoselective synthesis of cis-2,6-disubstituted piperidines 200, and alkaloid (+)-241D, from chiral imines (RS)-14.
available starting material [140]. Key steps of the synthesis are
the diastereoselective addition of 4-pentenylmagnesium bro-
mide to chiral imine (SS)-14 (R = 4-BrC6H4). Two diastereoiso-
mers 197 were isolated in 94% yield and moderate diastereose-
lectivity. The major component of the mixture was transformed
into compound 198 through a Hoveyda–Grubbs second genera-
tion cross metathesis with ethyl acrylate. Another key step was
the intramolecular aza-Michael reaction promoted by cesium
carbonate as base in dimethylacetamide (DMA), leading to 2,6-
trans-piperidine derivative 199 in high yield (Scheme 48). This
compound was an intermediate in the synthesis of a novel class
of anti-infective agents.
The base-promoted decarboxylative Mannich coupling of chiral
imines (RS)-14 [derived from an aldehyde R1CHO and (R)-tert-
butanesulfinamide] with these reagents provided β-amino ke-
tone derivative 200 in high yields and diastereoselectivities
[120]. These compounds were easily transformed into cis-2,6-
disubstituted piperidin-4-ones 201 through a ʟ-proline
organocatalyzed intramolecular Mannich reaction with a second
aldehyde (R2CHO). Almost no diastereoselectivity was ob-
served when R1 and R2 were aromatic rings. On the other hand,
aliphatic aldehydes gave in general excellent enantiomeric
ratios (>90:10). It is important to note that the order of reaction
of carbonyl compounds R1CHO and R2CHO with tert-butane-
sulfinamide to form chiral imine 14, or in the intramolecular
organocatalyzed condensation, determined the absolute configu-
ration of compounds 201 [141]. The usefulness of this method-
ology was demonstrated in the synthesis of the alkaloid
(+)-241D (202), isolated from the skin of the Panamanian
poison frog Dendrobates speciosus, through the reduction of
piperidin-4-one 201 (R1 = Me, R2 = n-C9H19) with lithium
borohydride (Scheme 49).
The base-catalyzed addition of 4-nitrobutanoates 203 to N-tert-
butanesulfinyl imines (RS)-14 under solvent-free reaction condi-
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Scheme 50: Stereoselective synthesis of 6-substituted piperidines-2,5-diones 206 and 1,7-diazaspiro[4.5]decane-2,8-diones 208 from chiral imines
(RS)-14.
Scheme 51: Stereoselective synthesis of spirocyclic oxindoles 210 from chiral imines (RS)-53.
tions proceeded with high facial diastereoselectivity. The result-
ing β-nitroamine derivatives 204 were easily transformed into
5-nitro-6-substituted piperidine-2-ones 205, upon removal of
the sulfinyl group with concomitant δ-lactam formation. Further
transformation of the nitro group under Nef-type reaction condi-
tions led to enantioenriched 6-substituted piperidine-2,5-diones
206 [142]. Interestingly, from compounds 205, and following a
two-step process, involving conjugative addition to ethyl acry-
late with formation of 207 as a single diastereoisomer, and final
reduction of the nitro group with Raney-nickel, 1,7-
diazaspiro[4.5]decane-2,8-diones 208 were accessed in a highly
stereoselective fashion (Scheme 50) [143].
A large number of biologically active natural products and syn-
thetic pharmaceutical drugs contain the 3-aminooxidole motif.
Chen and Xu demonstrated that the zinc-mediated allylation of
chiral oxindole sulfinyl imines (RS)-53 with allylic bromides
proceeded smoothly at room temperature in a mixture of THF
and HMPA, and a wide range of highly enantiomerically
enriched 3-allyl-substituted 3-aminooxindoles 209 were pre-
pared. The observed diastereofacial selectivity was rationalized
by considering an acyclic transition state model. The addition of
the allylic reagent occurred to the less hindered Re face of the
imine with (RS)-configuration. N-Allylation of compounds 209,
followed by ring-closing metathesis with Grubbs second gener-
ation catalyst, and removal of the sulfinyl group, led to chiral
spirocyclic aminooxindoles 210  in reasonable yields
(Scheme 51) [144].
Azaspirocyclic alkaloids with interesting pharmacological prop-
erties have been isolated from skin extracts of dendrotabic
frogs, and also from methanol extracts of ants of the species
Beilstein J. Org. Chem. 2021, 17, 1096–1140.
1125
Scheme 52: Stereoselective synthesis of azaspiro compound 213 from chiral imine 211.
Carabella bicolor. Amongst these alkaloids, (−)-histrionico-
toxin displays a potent noncompetitive acetylcholine antagonist
activity. It was found that perhydrohistrionicotoxin analogues
display similar biological properties. In this regard, Peralta-
Hernández and Cordero-Vargas reported the synthesis of an ad-
vanced synthetic intermediate 213 of perhydrohistrionicotoxin
[145]. The diastereoselective nucleophilic addition of a lithium
acetylide to cyclic chiral N-tert-butanesulfinyl imine 211 is a
key step in this strategy. The addition proceeded with total
stereocontrol to give a single diastereoisomer, and further
removal of the silyl group provided propargylamine derivative
212. Partial hydrogenation of this compound under Lindlar
conditions led to terminal olefin, which reacted with ethyl iodo-
acetate in refluxing dichoroethane, in the presence of 1.6 equiv-
alents of lauroyl peroxide (DLP), as thermal initiator of the
radical process. A spirolactam was isolated in 45% yield, taking
place under the essayed reaction conditions successively a
radical addition of the enolate to the terminal alkene, lactoniza-
tion and removal of the sulfinyl group. Final deprotection of the
hydroxy group led to compound 213, a precursor of the 6-(R)
epimer of perhydrohistrionicotoxin (Scheme 52).
Chiral aromatic sulfinyl imines 214 with a 2-haloethyl substitu-
ent at ortho-position were effective synthetic intermediates in
the stereoselective preparation of 1-aryl-1,2,3,4-tetrahydroiso-
quinolines, which are compounds that display interesting bio-
logical activities. For instance, solifenacin (216), a competitive
muscarinic acetylcholine receptor antagonist currently used in
the treatment of overactive bladders, was prepared from
(RS)-214a (X = Br) by addition first of phenylmagnesium bro-
mide at –40 °C in toluene. A 93:7 diastereomeric mixture was
obtained and the major diastereoisomer was easily isolated after
column chromatography. Subsequent intramolecular cycliza-
tion in the presence of NaH in DMF at room temperature gave
the pure diastereomer 215, a precursor of solefinacin (216)
[146]. Diastereoselective allylation of chlorinated derivative
(RS)-214b (X = Cl) with allylmagnesium bromide in dichloro-
methane gave the corresponding homoallylic sulfinamide as a
9:1 mixture of easily separable diastereoisomers, and the major
component of the mixture was further cyclized to give product
217, which was transformed after 5 steps into almorexant (218),
a non-peptide antagonist of the human orexin receptor, which
plays a major role in controlling the sleep/wake cycle [147].
The same precursor (RS)-214b (X = Cl) and strategy was fol-
lowed in the first steps of the synthesis of compound 220, used
as neuroprotective agents in the treatment of neurological
diseases, such as epilepsy and ischemia. In this case, the addi-
tion of 4-chlorophenylmagnesium bromide to (RS)-214b gave
the expected product with 93:7 ratio of diastereoisomers. An
intramolecular cyclization of the major diastereoisomer
afforded 219 in high yield (Scheme 53) [146].
Asymmetric synthesis of pyrrolizidines,
indolizidines and quinolizidines
Bicyclic systems containing bridgehead nitrogen, such as 1-aza-
bicyclo[3.3.0]octanes, 1-azabicyclo[4.3.0]nonanes and 1-azabi-
cyclo[4.4.0]decanes are structural motifs frequently encoun-
tered in alkaloids, which can come from quite diverse sources,
such as bacteria, fungi, plants and animals, among others. Many
of these natural products display extremely potent biological ac-
tivities and their syntheses, along with that of structurally
related analogs, remain of great interest for chemists and phar-
macologists. Relevant contributions regarding the synthesis of
these bicyclic compounds, involving chiral N-tert-butane-
sulfinyl imines, are compiled in the following paragraphs.
Initial stereocontrol by allylation of sulfinyl imines
The allylation of chiral N-tert-butanesulfinyl imines is of great
synthetic interest because in this reaction together with a new
functionality (amino derivative group), a carbon–carbon bond is
formed. In addition, the double bond of the allylic moiety can
participate in a number of further synthetically useful transfor-
mations, including the generation of functional groups prone to
participate in intramolecular cyclization processes involving the
nitrogen atom of the starting imine. Interestingly, the allylation
of these imines can be carried out in a stereoselective fashion
with different allylating reagents [66,148,149].
Pyrroloisoquinoline alkaloid (−)-crispine A (223) was isolated
from Carduus crispus plants which were used in folk medicine
for the treatment of different inflammatory diseases, such as
bronchitis, stenocardia, gastroenteritis, and rheumatism. In addi-
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Scheme 53: Stereoselective synthesis of tetrahydroisoquinoline derivatives from chiral imines (RS)-214.
Scheme 54: Stereoselective synthesis of (−)-crispine A 223 from chiral imine (RS)-214.
tion, it also shows promising biological activity against human
cancer cell lines. The allylation of chiral imine (RS)-214 with
allylmagnesium bromide in dichloromethane at −78 °C was the
key step in the synthesis reported by Reddy and co-workers of
this alkaloid. The allylated product was obtained in 80% yield
as 9:1 mixture of diastereoisomers, and the major diastereoiso-
mer was separated from the mixture and cyclized to give tetra-
hydroisoquinoline 217 (see above, Scheme 53). The formation
of the 5-membered ring to produce target (−)-crispine A (223)
was accomplished in six additional steps which comprise
removal of the sulfinyl group and subsequent N-Boc protection
to give 221, hydroboration–oxidation to produce terminal
alcohol derivative 222, and formation of the mesylate, removal
of the Boc group, and final cyclization (Scheme 54) [150].
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Scheme 55: Synthesis of (−)-harmicine (228) using tert-butanesulfinamide through haloamide cyclization.
A similar strategy was described by the same authors for the
stereoselective synthesis of (−)-harmicine and other tetrahydro-
β-carboline alkaloids. The allylation of chiral imine (RS)-225
with allylmagnesium bromide in dichloromethane at −78 °C
was the key step for the synthesis reported by Reddy and
co-workers that led to compound 226 in 81% yield (dr > 99:1).
After a sequence of similar steps of removal of the sulfinyl
group, protection of the amine, hydroboration–oxidation and
formation of the mesylate, removal of the Boc group, and final
cyclization, the (−)-harmicine (228) was obtained in 72% yield
in the last step [151] (Scheme 55).
Tetraponerines T1–T8 are tricyclic alkaloids with aminal struc-
ture, and depending on the size of the A–B–C rings, they are
divided in two groups (5−6−5: T1, T2, T5, T6; or 6−6−5: T3,
T4, T7, T8). Other differentiating elements are the alkyl chain
at C5-position (n-propyl: T1–T4; n-pentyl: T5–T8), and the
configuration of this stereocenter [(R): T1, T3, T5, T7; (S): T2,
T4, T6, T8] (Scheme 56). The stereocontrolled synthesis of
these alkaloids was reported by Bosque et al. Key step transfor-
mations in the stereoselective synthesis of each natural
tetraponerine are two consecutive indium-mediated aminoally-
lations of the appropriate stereoisomer of a chiral N-tert-butyl-
sulfinamide. Allylpyrrolidine derivative 238, which is the pre-
cursor of 5−6−5 tetraponerines (T1, T2, T5, T6; 185–187), was
obtained from 4-bromobutanal (231) in the first aminoallyla-
tion, and allyl piperidine derivative 126 (see Scheme 32; precur-
sor of 6−6−5 tetraponerines: T3, T4, T7, T8; 231, 233, 235 and
237, respectively) was prepared from 5-bromopentanal. Impor-
tantly, to prepare tetraponerines T5–T8, with a pentyl group at
C5-position, a cross-metathesis reaction involving the allyl
group of the second aminoallylation with cis-3-hexene was
carried out in order to elongate the side chain [152,153]. The
anticancer activity of tetraponerines T5–T8 against four differ-
ent carcinoma human cell lines was also investigated, observing
a promising cytotoxic activity of tetraponerine T7 (236) against
breast carcinoma cell line MCF-7 [152].
Taking advantage of this highly diastereoselective indium-
mediated amino allylation of carbonyl compounds, an efficient
stereocontrolled synthesis of phenanthroindolizidines 246 and
phenanthroquinolizidine 7-methoxycryptopleurine 248 was
accomplished by Antón-Torrecillas et al., using 2-(phenanthren-
9-yl)acetaldehydes 243 as starting materials. The initially
formed homoallylamine derivatives 244 were transformed first
into pyrrolidines 245 (hydrobroration–oxydation–intramolecu-
lar Mitsunobu N-alkylation), and after removal of the sulfinyl
group, and a Pictet–Spengler reaction involving formaldehyde,
the expected phenanthroindolizidine 246a and the alkaloid
(−)-tylophorine (246b) were obtained (Scheme 57) [154]. On
the other hand, key chiral homoallyllic sulfinamine intermedi-
ate 244b was also transformed in four steps into enantio-
enriched 7-methoxycryptopleurine 248, a rhodium-catalyzed
linear hydroformylation being one of the steps involved in the
formation of piperidine derivative 247. Cytotoxic evaluation of
both enantiomers of 7-methoxycryptopleurine demonstrated
that the compound with (R)-configuration shown in Scheme 57
was much more potent than its antipode against four cancer cell
lines examined [155]. Phenanthroquinolizidines with a quater-
nary center at C-14a position, bearing a methyl group instead of
the proton, were prepared following the same methodology, and
using the corresponding methyl ketone as starting material.
These compounds displayed also cytotoxic activity against dif-
ferent human cancer cell lines [156].
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Scheme 56: Stereoselective synthesis of tetraponerines T1–T8.
Scheme 57: Stereoselective synthesis of phenanthroindolizidines 246a and (−)-tylophorine (246b), and phenanthroquinolizidine 248.
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Scheme 58: Stereoselective synthesis of indoline, tetrahydroquinoline and tetrahydrobenzazepine derivatives 253 and 255 from chiral aldimines (SS)-
250.
Indium-mediated allylation of sulfinyl imines was also the
source of the stereocontrol in the synthesis of benzo-fused
1-azabicyclo[j.k.0]alkanes 253 and 255 reported by Sirvent et
al.. The starting chiral imines (SS)-250 derived from aliphatic
aldehydes, with a 2-bromophenyl substituent, and (S)-tert-
butanesulfinamide. When the allylation was carried out with
ethyl 2-(bromomethyl)acrylate (249), and after removal of the
sulfinyl unit, the resulting free amine derivative led to α-methy-
lene-γ-butyrolactams 252. On the other hand, dihydropyridin-2-
ones 254 were obtained after sequential allylation with allyl
bromide 251, desulfinylation, acylation with acryloyl chloride,
and ring-closing metathesis. Lactams 252 and 254 were easily
transformed into target polycyclic compounds 253 and 255 by
performing an intramolecular N-arylation using Ullmann-type
reaction conditions (Scheme 58) [157].
The group of Wei reported a diastereoselective approach for the
synthesis of trans-4-hydroxy-5-allyl-2-pyrrolidinone 80 through
an indium-mediated allylation of α-chiral aldimine (RS)-79 (see
above Scheme 24) [100]. Allyl pyrrolidone 80 was an interme-
diate in the synthesis of alkaloids (+)-epohelmins A (258) and B
(260). These natural products were isolated from an unidenti-
fied fungus, and inhibited recombinant lanosterol synthase with
low IC50 values, with potential use as anticholesteraemic drugs
to complement or even substitute the now widely used members
of the statin family. The second five-membered ring of the
pyrrolizidinic system in (+)-epohelmin A (258) was constructed
from alcohol 257, upon forming the corresponding mesylate,
subsequent removal of the Boc group, promoting cyclization,
and final desilylation. Compound 256 was the last common
intermediate in the diastereodivergent approach to both
epohelmins, the corresponding epimer 259 was the precursor of
(+)-epohelmin B (260) by applying the same reaction condi-
tions as for (+)-epohelmin A (258, Scheme 59) [158].
The addition of a lithium anion of N-(diphenylmethyl-
idene)allylimine (262) to chiral sulfinyl imines was investigat-
ed by Prasad and co-workers. They found that the reaction with
imines derived from aliphatic aldehydes afforded 1,2-diamine
derivatives with excellent diastereoselectivity (>99:1). Allyla-
tion of chiral imine (SS)-261 with concomitant cyclization led to
piperidine 263 as a single diastereoisomer. Removal of
diphenylmethylidene group and acylation of the resulting free
amine provided compound 264, which after desulfinylation,
N-allylation, ring-closing metathesis and catalytic hydrogena-
tion produced the quinolizidine alkaloid (−)-epiquinamide
(266), isolated from the skin of the Ecuadoran frog Epipedo-
bates tricolor (Scheme 60) [159].
Fustero and co-workers described for the first time the use of
N-tert-butanesulfinamide in a desymmetrization-type process
involving an intramolecular aza-Michael reaction for obtaining
the advanced intermediates 271a and 271b in the total synthe-
sis of (−)-hippodamine (273) and (+)-epi-hippodamine (272).
The condensation reaction between the symmetric ketone 267
and (R)-N-tert-butanesulfinamide in the presence of
titanium(IV) ethoxide followed by the reductive amination with
NaBH4 and double-direction cross-metathesis reaction led to
268a in 50% yield and 268b in 49% yield. These compounds
were submitted to the desymmetrization process by an intramo-
lecular aza-Michael reaction using NaH in THF. The applied
conditions yielded a mixture of cis-269 and trans-269 diastereo-
isomers as major product (cis/trans 3:1) and a small amount of
other possible isomer 270 was detected (269a/270a 95:5) and
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Scheme 59: Stereoselective synthesis of (+)-epohelmin A (258) and (+)-epohelmin B (260) from aldimine (RS)-79.
Scheme 60: Stereoselective synthesis of (−)-epiquinamide (266) from chiral aldimine (SS)-261.
(269b/270b 96:4). The addition of nitrogen nucleophile
occurred to the Si face of the conjugated ester, opposite to the
bulky tert-butyl group gave cis-269a,b as major isomer
(Scheme 61). The sulfoxide auxiliary was removed under acid
conditions, and after a basification process with saturated
aqueous NaHCO3, a second intramolecular aza-Michael reac-
tion took place to the products 271a and 271b with excellent
yields and high diastereoselectivity. Since 271a,b is C2-sym-
metric, the cyclization of cis-269a,b or trans 269a,b as soon as
270a,b gave the same isomer 271. Consequently, 271a was ob-
tained in 90% ee and 271b in >99% ee, as determined by chiral
HPLC analysis. After three steps, a mixture of (−)-hippo-
damine (273) and (+)-epi-hippodamine (272) were obtained in
high yield which was separated by column chromatography
[160] (Scheme 61).
Stereocontrol synthesis through addition of
Grignard reagents to N-sulfinyl imines
The group of Lindsley developed new methodologies for the
enantioselective synthesis of different azabicyclic systems.
These methodologies are based on the diastereoselective addi-
tion of Grignard reagents to chiral sulfinyl imines, and applied
to the syntheses of the indolizidine alkaloid (+)-grandisine D
(279) [161], and pyrrolizidine alkaloid (+)-amabiline (283)
[162], starting from imine 274. The addition of a masked acetal
organomagnesium compound to sulfinyl imine 274 provided
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Scheme 61: Synthesis synthesis of (–)-hippodamine (273) and (+)-epi-hippodamine (272) using chiral sulfinyl amines.
compound 275 in high yield and diastereoselectivity, which
after reaction with the appropriate alkylating reagent led to 276
and 280. These compounds were prone to undergo ring-closing
metathesis, generating 6- and 5-membered ring systems, respec-
tively. After several steps, acetal derivatives 278 and 282 were
transformed into (+)-grandisine D (279) and (+)-amabiline
(283). Treatment under acidic conditions of 278 and 282 pro-
duced removal of the sulfinyl group and hydrolysis of the
acetal, revealing the masked aldehyde. In the final step, an
intramolecular hydroamination allowed the formation of the
five-membered ring, to complete the construction of the azabi-
cyclic arrays (Scheme 62). The indolozidine alkaloids gran-
disines were isolated from leaves of the Australian rain forest
tree Elaeocarpus grandis, and these alkaloids display selective
human δ-opioid receptor affinity. Meanwhile, hepatotoxic
(+)-amabiline (283) was found in the seeds and flowers of
Borago officinalis.
The addition of alkynyl or alkenyl Grignard reagents to chiral
sulfinyl imine (SS)-126 led to 6-substituted trans-5-hydroxy-2-
piperidinones with high diastereoselectivity, which is con-
trolled mainly for the configuration of the stereocenter bearing
the silyloxy group with alkenyl reagents, and by the coordina-
tion of the silyloxy substitution and stereochemistry of the sulfi-
namide with alkynyl organomagnesium compounds. The addi-
tion of vinylmagnesium bromide to (SS)-126 led, after N-Boc
protection to 2-piperidinone 284, a precursor of diolefin 285,
which through ring closing metathesis allowed the synthesis of
quinolizidinone 286, from which (−)-epiquinamide (266) was
prepared after three steps. On the other hand, the reaction of
imine (SS)-126 with ethynylmagnesium bromide provided com-
pound 288, which was transformed into the N-allyl-substituted
piperidinone 289. Again, a ring-closing metathesis allowed the
formation of the bicyclic indolizidinone system 290, an ad-
vanced synthetic intermediate of alkaloid (+)-swainsonine (291,
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Scheme 62: Stereoselective synthesis of (+)-grandisine D (279) and (+)-amabiline (283).
Scheme 63) [163]. This alkaloid was found in the fungus
Rhizoctonia leguminicola and in plants such as the Australian
Swainsona canescens and the North American locoweed Astra-
galus lentiginosus. It displays a wide range of biological activi-
ties, including alteri neoplastic growth and metastasis.
Stereocontrol synthesis through Mannich,
nitro-Mannich and Mukaiyama–Mannich
reactions of N-sulfinyl imines
Heterocyclic compounds can be obtained through strategies
using Mannich reactions [164-166]. It was previously
commented that the addition of ethyl 4-nitrobutanoante (203) to
chiral sulfinyl imines under basic solvent-free conditions
proceeded with high facial diastereoselectivity (Scheme 64
[143]). When the reaction was performed with the imine of
5-bromopentanal, (RS)-76, the nitro-Mannich adduct 292 was
formed in 86% yield as a 1:1 mixture of diastereoisomers,
considering the stereocenter bearing the nitro group. Taking
advantage of this methodology, Benlahrech et al. reported the
synthesis of (+)-C(9a)-epi-epiquinamide (294) [167]. Desulfiny-
lation of compound 292 led to quinolizidine derivative 293,
taking place two consecutive cyclizations involving the result-
ing free amino group, the ester and the alkyl bromide function-
alities. Although compound 292 was isolated in a 1:1 dr, quino-
lizidine 293 was formed as a 6:1 mixture of diastereoisomers,
due to a rapid epimerization under basic conditions, leading to
the thermodynamic most stable isomer. Sequential reductions of
the nitro group, the lactam and final N-acetylation of the prima-
ry amine were the last steps of this synthesis (Scheme 64).
The Lewis acid-promoted addition of silyl enol ethers to chiral
sulfinyl imines afforded β-amino ketones in high yields and dia-
stereoselectivities (see above Scheme 24 [100]). Similar levels
of stereoselectivity were found performing this type of
Mukaiyama–Mannich reactions with enol ethers derived from
methyl-conjugated enones. The reaction of chiral imine
(SS)-109 with silyl enol ether 295 led to β-amino enone 296.
Removal of the sulfinyl group under acidic conditions and
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Scheme 63: Stereoselective synthesis of (−)-epiquinamide (266) and (+)-swaisonine (291) from aldimine (SS)-126.
Scheme 64: Stereoselective synthesis of (+)-C(9a)-epi-epiquinamide (294).
subsequent basic treatment with DBU led, after N-alkylation
and intramolecular conjugate addition, to cis-quinolizidinone
297 in 41% yield (35% of the trans-isomer). Reduction of the
ketone functionality with LAH gave 2-epi-lasubine II, and
Mitsunobu inversion of the configuration provide (+)-lasubine
II (298) in 81% yield (Scheme 65) [168].
A straightforward synthesis of the alkaloids (−)-epimyrtine
(300a) and (−)-lasubine II (ent-302) from β-amino ketone
derivatives 204 was reported by Lahosa et al. These
compounds participate in a ʟ-proline organocatalyzed
intramolecular Mannich reaction with a second aldehyde
(R2CHO) to give cis-2,6-disubstituted piperidin-4-ones 205 (see
above Scheme 49 [141]). However, when one of the
aldehydes involved in the formation of β-amino ketone 204
(R1CHO) or in the intramolecular Mannich reaction (R2CHO)
which is 5-chloro- or 5-bromopentanal, quinolizidinone
derivatives 299 or 300 are formed. In both cases, after
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Scheme 65: Stereoselective synthesis of (+)-lasubine II (298) from chiral aldimine (SS)-109.
Scheme 66: Stereoselective synthesis of (−)-epimyrtine (300a) and (−)-lasubine II (ent-302) from β-amino ketone derivatives 204.
formation of the piperidine ring through the expected Mannich
condensation, a subsequent intramolecular N-alkylation involv-
ing the carbon–halogen bond occurred to produce the quinolizi-
dinic systems. The natural alkaloid (−)-epimyrtine (300a), iso-
lated from bilberry (Vaccinium myrtillus) was prepared
following this methodology, along with ent-299b, which was
transformed in a single step into (−)-lasubine II (ent-302), by
diastereoselective reduction with ʟ-selectride (Scheme 66)
[141].
Andrade [8,169,170] and Zhao reported an elegant and effi-
cient methodology for the rapid assembling of chiral N-tert-
butanesulfinyl imine (RS)-303 with methyl 2-ethylacrylate to
give tricyclic derivative 305, in high yield and diastereoselectiv-
ity. Treatment of (RS)-303 with LiHMDS in THF at –78 °C led
to the formation of lithiodienamine intermediate 304, which
reacted with methyl 2-ethylacrylate, leading to the Michael ad-
dition product, and the resulting enolate participated in an intra-
molecular Mannich reaction to form a six-membered ring. Final
addition of an excess of allyl bromide yielded tetrahydro-
carbazole 305 in 90% yield. After convenient functional group
transformation, diolefin 306 was submitted to ring-closing me-
tathesis to form tetracycle 307. Further removal of the sulfinyl
group and N-alkylation with 2-bromoethanol gave compound
308, which is an ideal substrate for the construction of the five-
membered ring leading to spiro compound 309, upon reaction
with potassium tert-butoxide (Bosch−Rubiralta spirocycliza-
tion). Treatment of 309 with LDA at –78 °C and quenching the
resulting metalloenamine with methyl cyanoformate furnished
(−)-tabersonine (310), and selective hydrogenation of 310 led to
(−)-vincadifformine (311). In addition, double hydrogenation of
309 produced (−)-aspidospermidine (312) in 75% yield. All
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Scheme 67: Stereoselective synthesis of (−)-tabersonine (310), (−)-vincadifformine (311), and (−)-aspidospermidine (312).
these alkaloids are members of the Aspidosperma family
(Scheme 67) [171,172].
Stereocontrol by pinacol-type coupling
reactions involving N-sulfinyl imines
The alkaloids (+)-epohelmin A (258) and (+)-epohelmin B
(260) were prepared from chiral aldehyde 313 and chiral
sulfinyl imine 314, through samarium iodide-induced reductive
cross-coupling reaction leading to compound 315 in 76% yield,
and total diastereoselectivity. After several steps, enone amino
triol derivative 316 was prepared and directly transformed into
(+)-epohelmin A (258), by applying the same reaction condi-
tions shown in Scheme 59 [158] for the transformation of
pyrrolidine derivative 257 into (+)-epohelmin A (258). The
epimer (+)-epohelmin B (260) was also prepared from 258,
carrying out an oxidation of the alcohol and a diastereoselec-
tive reduction with ʟ-selectride of the resulting cyclic ketone
(Scheme 68) [173].
Asymmetric synthesis of lysergic acid
In 2013, Liu and colleagues used N-tert-butanesulfinamide in
the total synthesis of (+)-lysergic acid (323). The first step was
the aminoallylation of aldehyde 317 with allyl bromide and
sulfinamide (RS)-1 by means of indium metal, leading to
homoallyl derivative 318. Further steps included an N-alkyl-
ation and ring-closing metathesis with Grubbs second genera-
tion catalyst to generate tetrahydropyridine 320 in high yields.
Removal of the silyl protecting group, followed by oxidation of
the resulting terminal alcohol and palladium-catalyzed cou-
pling of the aldehyde with 3-chloro-2-iodoaniline afforded
indole derivative 322, which is an advanced precursor of target
(+)-lysergic acid (323, Scheme 69) [174].
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Scheme 68: Stereoselective synthesis of (+)-epohelmin A (258) and (+)-epohelmin B (260) from aldehyde 313 and aldimine 314.
Scheme 69: Total synthesis of (+)-lysergic acid (323) from N-tert-butanesulfinamide (RS)-1.
Conclusion
Important progress has been made in the development of meth-
odologies that make use of stable N-tert-butanesulfinyl imines
as chiral reagents in diverse synthetic transformations, being
possible to recover the chiral auxiliary at the end of the reaction.
The great value of enantiomerically enriched amines as synthe-
tic intermediates in the route to complex organic molecules, in-
cluding natural products (mostly, alkaloids), has boosted the de-
velopment of nucleophilic addition protocols to these
Davis–Ellman N-sulfinyl imines, since the pioneering work of
Davis`s group and subsequent work of Ellman`s group. Interest-
ingly, the existing working models facilitate the prediction of
the major diastereoisomer in most cases, making this technolo-
gy attractive with the aim of synthetic applications.
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